Germany's Merck Lifts Outlook as Profit Jumps
12 Novembro 2015 - 7:10AM
Dow Jones News
FRANKFURT—German pharmaceutical and chemicals group Merck KGaA
on Thursday reported a jump in third quarter profit and lifted its
outlook for 2015 to take account of its acquisition of U.S.-based
Sigma-Aldrich.
Third-quarter net profit rose to €364 million ($391.46 million)
from €248.8 million a year earlier.
Merck's closely watched earnings before interest, taxes,
depreciation and amortization, or Ebitda before one-time items,
jumped 10% to €944 million, beating analysts' forecasts of €888
million, driven by a strong operational performance.
Sales rose 6.8% to €3.1 billion, helped by currency gains.
Analysts expected €3.18 billion.
Merck now sees 2015 net sales in a range of between €12.6
billion and €12.8 billion, up from a previous forecast of between
€12.3 billion and €12.5 billion. Ebitda before one-time items is
now seen in a range of €3.58 billion and €3.65 billion. Merck
previously expected €3.45 billion to €3.55 billion.
The outlook now factors in the company's imminent $17 billion
acquisition of U.S.-based Sigma-Aldrich Corp., a supplier of
laboratory testing materials. Merck expects to obtain control of
Sigma-Aldrich on Nov. 18, 2015
Write to Natascha Divac at natascha.divac@wsj.com
Access Investor Kit for "Merck KGaA"
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=DE0006599905
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
November 12, 2015 03:55 ET (08:55 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
(MM) (NASDAQ:SIAL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
(MM) (NASDAQ:SIAL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
